Thomas Högberg
1 – 50 of 67
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Increased incidence and improved survival in endometrial cancer in Sweden 1960-2014 : a population-based registry survey
(
- Contribution to journal › Article
- 2022
-
Mark
The wait time to primary surgery in endometrial cancer–impact on survival and predictive factors : a population-based SweGCG study
(
- Contribution to journal › Article
-
Mark
Long-term incidence of endometrial cancer after endometrial resection and ablation : A population based Swedish gynecologic cancer group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide
(
- Contribution to journal › Scientific review
-
Mark
Time Trends for Incidence and Net Survival of Cervical Cancer in Sweden 1960-2014 - A Nationwide Population-Based Study
(
- Contribution to journal › Article
- 2021
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
-
Mark
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014 : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2020
-
Mark
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma : A population-based SweGCG study
(
- Contribution to journal › Article
- 2019
-
Mark
Primary treatment patterns and survival of cervical cancer in Sweden : A population-based Swedish Gynecologic Cancer Group Study
(
- Contribution to journal › Article
-
Mark
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2018
-
Mark
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2017
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
(
- Contribution to journal › Article
-
Mark
Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
(
- Contribution to journal › Article
-
Mark
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer : A phase III, randomised, multicentre trial (Ovaresist)
(
- Contribution to journal › Article
- 2016
-
Mark
Long term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
(
- Contribution to journal › Article
-
Mark
A population-based registry study evaluating surgery in newly diagnosed uterine cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Robot-assisted surgery in cervical cancer patients reduces the time to normal activities of daily living.
(
- Contribution to journal › Article
-
Mark
Hopp om förbättring av överlevnad i ovarialcancer
(
- Contribution to journal › Article
- 2011
-
Mark
Adjuvant chemotherapy for endometrial cancer after hysterectomy
(
- Contribution to journal › Scientific review
-
Mark
What is the Role of Chemotherapy in Endometrial Cancer?
(
- Contribution to journal › Article
-
Mark
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours
2010) 35th European-Society-for-Medical-Oncology (ESMO) Congress In Annals of Oncology 21(Suppl. 8). p.177-178(
- Contribution to journal › Published meeting abstract
-
Mark
CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Adjuvant chemotherapy in endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies
(
- Contribution to journal › Article
- 2008
-
Mark
Adjuvant Chemotherapy in Endometrial Carcinoma: Overview of Randomised Trials.
(
- Contribution to journal › Article
- 2005
-
Mark
2004 consensus statements on the management of ovarian cancer : final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16 Suppl 8. p.7-12(
- Contribution to journal › Article
-
Mark
Clinical trials in ovarian carcinoma : study methodology
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.20-29(
- Contribution to journal › Article
-
Mark
3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38(
- Contribution to journal › Article
- 2002
-
Mark
Med P:n som i programpaket. Om datatortyr och signifikansfiskeri
(
- Contribution to journal › Article
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
(
- Contribution to journal › Scientific review
-
Mark
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions
(
- Contribution to journal › Scientific review
- 2000
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
-
Mark
Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix
(
- Contribution to journal › Article
- 1998
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
(
- Contribution to journal › Article
-
Mark
Nytt behandlingsprogram vid avancerad ovarialcancer. Tillfredsställande resultat med decentraliserad cytostatikaterapi
(
- Contribution to journal › Article
- 1997
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article
-
Mark
Bättre prognos vid epitelial ovarialcancer
(
- Contribution to journal › Article
-
Mark
Malignant struma ovarii' with peritoneal dissemination
(
- Contribution to journal › Letter
-
Mark
Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?
(
- Contribution to journal › Article
- 1996
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article
-
Mark
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
(
- Contribution to journal › Article
-
Mark
Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group
(
- Contribution to journal › Article
- 1995
-
Mark
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
(
- Contribution to journal › Article
-
Mark
Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study
(
- Contribution to journal › Article
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article